Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

MDS 2023 | Wilson’s disease: understanding the impact on movement disorders

Prashanth Kukkle, PhD, Center for Parkinson’s Disease and Movement Disorders Clinic Vikram Hospitals, Bangalore, India, explores Wilson’s disease, a condition named after Samuel Wilson, who first described its symptoms in 1912. Wilson’s disease is characterized by impaired copper metabolism, leading to an accumulation of copper in various parts of the body, including the liver, brain, eyes, and musculoskeletal system. This deposition of copper can result in a range of symptoms, such as jaundice, behavioral changes, dystonia, tremors, and even parkinsonism. Dr Kukkle highlights how Wilson’s disease has significantly contributed to understanding movement disorders and the extrapyramidal system. Importantly, the therapeutic benefits available to those with Wilson’s disease offer hope for improved health outcomes. This interview took place at the 2023 International Congress of Parkinson’s Disease and Movement Disorders in Copenhagen, Denmark.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.